A pilot study to determine the effects of corticotrophin releasing hormone (CRH) on myocardial function

ISRCTN ISRCTN18842004
DOI https://doi.org/10.1186/ISRCTN18842004
Protocol serial number N0295132800
Sponsor Department of Health
Funder University Hospitals Coventry and Warwickshire NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
07/07/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Harpal Randeva
Scientific

Metabolic Unit
Coventry & Warwickshire Hospital
Stoney Stanton Road
Coventry
CV1 4FH
United Kingdom

Phone +44 (0)2476 844091/572552
Email harpal.randeva@uhcw.nhs.uk

Study information

Primary study designInterventional
Study designDouble-blind randomised crossover pilot study
Secondary study designRandomised cross over trial
Study type Participant information sheet
Scientific titleA pilot study to determine the effects of corticotrophin releasing hormone (CRH) on myocardial function
Study objectivesWhat is the effect of a single intravenous dose of CRH on myocardial contractility in normal, healthy subjects?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCardiovascular: Myocardial function
InterventionSingle intravenous dose of CRH
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Corticotrophin releasing hormone
Primary outcome measure(s)

Changes in measure of cardiac contractility/function as assessed by echocardiography: ejection fraction, fractional shortening, stroke volume, diastolic left ventricular filling, myocardial velocity, strain rate and strain.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/04/2004

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit60 Years
SexAll
Target sample size at registration10
Key inclusion criteriaHealthy men or women, 18-60 years of age.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment08/12/2003
Date of final enrolment30/04/2004

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Coventry & Warwickshire Hospital
Coventry
CV1 4FH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

07/07/2017: No publications found in PubMed, verifying study status with principal investigator.